According to a study published in the Cureus journal, mRNA COVID-19 vaccines caused more deaths than they saved.
A recent study found that mRNA COVID-19 vaccines have much lower efficiency rates and kill more people than they save. The researchers recommended a “global moratorium” on the vaccinations and their “immediate removal” from the pediatric immunization schedule.
The study, which underwent peer review, was published in the Cureus journal on January 24. It examined data from the phase 3 trials of the COVID-19 mRNA vaccines from Moderna and Pfizer. The United States approved the shots under Emergency Use Authorization (EUA) as a result of these studies. The investigation also examined several additional studies and trial evaluations. It was discovered that the vaccines’ efficacy rates were “dramatically lower” than those reported by the vaccine manufacturers.
Additionally, predicated on “conservative assumptions, the estimated harms of the COVID-19 mRNA vaccines greatly outweigh the rewards: for every life saved, there were nearly 14 times more deaths caused by the modified mRNA injections.”
“Given the well-documented SAEs (serious adverse events) and unacceptable harm-to-reward ratio, we urge governments to endorse and enforce a global moratorium on these modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.”
According to a report by the Telegraph, lab leaks have increased by 50% since the COVID-19 pandemic in the UK, with 156 instances of lab leaks or mishaps since January 2020.
The COVID-19 vaccines should be “immediately removed” from the childhood immunization schedule, according to the authors’ recommendation. They emphasized that youngsters had extremely little chance of contracting the virus.
“It is unethical and unconscionable to administer an experimental vaccine to a child who has a near-zero risk of dying from COVID-19 but a well-established 2.2 percent risk of permanent heart damage based on the best prospective data available.”
Very Low Efficacy Rate
It was reported that mRNA COVID-19 vaccines had a 95% reduction in symptomatic COVID-19 after the initial Pfizer and Moderna trials. It was revealed by the study that this efficacy assumption was untrue.
Pfizer’s assertion was supported by the finding that, during the trial, only eight out of 22,000 vaccination recipients contracted COVID-19, while 162 out of 22,000 participants in the placebo group did so. In both groups, a total of 170 confirmed COVID-19 cases were reported.
The researchers did note that a significant portion of infections were classified as “suspected” COVID-19, a classification that was disregarded. Twenty times as many suspected instances as verified cases—1,70—were found throughout the trial, totaling 3,410.
“There were 1,594 such cases in the vaccinated group and 1,816 in the placebo. When factoring in both confirmed and suspected cases, vaccine efficacy against developing symptoms drops to only 19 percent, far below the 50 percent RR (relative risk) reduction threshold required for regulatory authorization,” the study said.
“Thus, when considering both confirmed and suspected cases, vaccine efficacy appears to have been dramatically lower than the official 95 percent claim.”
The authors of the paper disclosed that they received no funding for their research from any institution. Disclosures about a few conflicts of interest were made.
Quanta Computer Inc. awarded a grant to one of the authors. Peter A. McCullough, a cardiologist and fellow author, disclosed his employment status and ownership of shares and stock options in The Wellness Company. The creator of the Vaccine Safety Research Foundation (VSRF) is a third author.
Lives Saved Versus Deaths
The Pfizer and Moderna trial findings drew criticism from researchers for their “exclusive focus” on relative risk, or RR measure, and omission of absolute risk reduction. Absolute risk reduction, they claimed, “gives a better indication of a drug’s clinical utility.”
“Both types of risk estimation are required to avoid reporting bias and to provide a more comprehensive perspective on vaccine efficacy. Omitting the absolute risk statistics leads to overestimation of the clinical benefits of the vaccines.”
The study found that the absolute risk reduction for the Pfizer and Moderna vaccines was 0.7 percent and 1.1 percent, respectively, compared with the 95 percent efficacy rate using the RR measure.
“An absolute risk reduction of approximately 1 percent for the COVID-19 mRNA vaccinations meant that a substantial number of individuals would need to be injected to prevent a single mild-to-moderate case of COVID-19.”
According to the study, 142 people would need to receive the Pfizer vaccine to stop one instance of COVID-19 infection. It was necessary to inject 88 persons with Moderna.
Based on these figures and COVID-19 infection mortality rates, the researchers calculated that around 52,000 vaccinations would be required to stop one COVID-19-related death.
This would equate to two lives saved for every approximately 100,000 Pfizer vaccine shots. However, the researchers concluded that there is a risk of 27 deaths per 100,000 doses of Pfizer injection. Therefore, the study found that the mRNA vaccine would result in the loss of nearly 14 lives for every life that was saved by the vaccination.
After analyzing vaccine data, the authors observed that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) “did not include absolute risk reduction measures.”
FDA rules, “which state that both approaches are crucial in order to avoid the misguided use of pharmaceuticals,” were violated by this move.
Serious Adverse Events
To illustrate the extent of significant adverse effects (SAE) among the trial’s vaccinated group, researchers used a study from September 2022. Based on a review of trial data from Pfizer and Moderna, around 125 SAEs were found for every 100,000 vaccination participants. This showed one SAE for every 800 shots.
“The Pfizer trial exhibited a 36 percent higher risk of serious adverse events in the vaccine group (compared to placebo) … The Moderna trial exhibited a 6 percent higher risk of serious adverse events in the vaccine group,” the analysis stated.
“These findings stand in sharp contrast with the FDA’s initial claim that SAEs reported by the two pivotal trials were ‘balanced between treatment groups,’” researchers from the Jan. 24 study noted.
According to them, the reason for this discrepancy might be that the FDA only counted the number of people who had significant adverse events (SAEs) rather than the entire number of SAEs that trial participants encountered.
Counting just individual SAEs would result in a lower number than the total number of such adverse events because one person can experience many SAEs.
“When the SAEs were viewed collectively, the risks in the vaccine group were substantially elevated beyond those previously determined by the FDA,” the researchers wrote.
According to the data, there was a 10.1 excess risk of serious adverse events of special interest (AESI) for every 10,000 participants in the vaccine group. But in the placebo group, the risk reduction for COVID-19 hospitalization was a mere 2.3 per 10,000 individuals.
This means that the risk of AESIs for the vaccinated patients was more than four times higher than the chance of hospitalization for the infection for the placebo subjects. Vaccinated individuals were more than twice as likely to experience AESI in the Moderna study.
“To put these findings in perspective, the official SAE rate for other vaccines is only 1-2 per million,” the Jan. 24 study said. The 2020 analysis’ “estimate based on the Pfizer trial data (1,250 SAEs per million) exceeds this benchmark by at least 600-fold.”
Rushed Vaccines
The safety of mRNA products was “never assessed” by scientific guidelines for vaccinations or gene therapy products (GPT), which they contend is “the more accurate classification” for these injections, according to researchers in the paper published on January 24. “A large number of significant trial results were either completely or inaccurately reported in published reports.”
The FDA and vaccine makers disregarded the standard toxicological requirements and safety testing procedures. There was never an “unbiased assessment” of potentially significant adverse events because the two studies ended abruptly.
“It was only after the EUA that the serious biological consequences of rushing the trials became evident, with numerous cardiovascular, neurological, reproductive, hematological, malignant, and autoimmune SAEs identified and published in the peer-reviewed medical literature.”
Furthermore, the COVID-19 mRNA vaccines generated and assessed in the studies were not the same as those created and given to individuals globally. The vaccine used in the global vaccination effort was made using a different method and has been demonstrated to have “varying degrees of DNA contamination.”
Since early 2021, more than a few additional deaths, cardiac incidents, strokes, and other major adverse events have been incorrectly linked to COVID-19 instead of the COVID-19 mRNA vaccinations, according to the researchers.
The injuries resulting from these vaccinations frequently obscure the vaccine’s role in the development of post-acute COVID-19 syndrome (PACS) and severe acute COVID-19 disease. “Immune dysfunction appears to be brought on by multiple booster injections, which ironically increases susceptibility to COVID-19 infections with subsequent doses.”
The perceived benefits of the mRNA vaccines were outweighed by their “potential disabling and life-threatening harm” for the “vast majority” of adults under 50. Older persons may be more vulnerable to such injury, according to the study.
CDC and FDA Criticized
The founder and head of the nonprofit Liberty Counsel, Mat Staver, commented on the report, saying that the researchers “confirm what sound scientific research has been showing for years, that these shots have never been safe nor effective.”
“The FDA and the CDC are supposed to protect the people, but they have become the lapdog of the pharmaceutical industry. This must change.”
The CDC is currently facing criticism for allegedly dissipating a warning about myocarditis linked to the COVID-19 vaccine. An inflammation of the myocardium, the heart muscle, is known as myocarditis.
The CDC prepared a draft notice for myocarditis associated with the vaccines in May 2021, according to a document that The Epoch Times has obtained.
Through its Health Alert Network (HAN), the organization was meant to notify physicians and public health officials at the federal, state, and municipal levels across the country. However, because some officials were concerned about being seen as “alarmist,” the alert was never delivered.
Support GreatGameIndia
